Status:
COMPLETED
Arterial Patency in Liver Transplantation
Lead Sponsor:
University of Zurich
Collaborating Sponsors:
University Hospital Birmingham NHS Foundation Trust
Medical University Innsbruck
Conditions:
Aortohepatic Conduit
Patency Rate
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to determine the risk profile of hepatic artery occlusion in liver transplant recipients who received an aortohepatic conduits, analyzing all consecutive cadaveric liver trans...
Detailed Description
BACKGROUND Arterial conduits in liver transplantation are almost as old as the procedure itself. First described by Starzl in 1984, the knowledge remains superficial. Although rarely performed, there...
Eligibility Criteria
Inclusion
- Liver transplantation requiring aorto-hepatic or iliac-hepatic conduits
- Deceased donor after brain death (DBD) or deceased donor after circulatory death (DCD)
- Whole organ as well as split allografts
- Primary liver transplantation as well as liver retransplantation
- Recipient age ≥18 years
Exclusion
- Living donor liver transplantation
- Pediatric liver transplantation (recipient age \<18 years)
- Arterial reconstruction other than aorto-hepatic or iliac-hepatic conduits
- Multivisceral transplantations
Key Trial Info
Start Date :
September 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
567 Patients enrolled
Trial Details
Trial ID
NCT03275883
Start Date
September 1 2017
End Date
December 1 2019
Last Update
March 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich
Zurich, Switzerland, 8091